|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
TER | MADDOCK ERNEST E | Director | Feb 01 | Buy | 94.07 | 1,000 | 94,070 | 4,728 | Feb 05 05:17 PM |
OUST | MADDOCK ERNEST E | Director | Nov 15 | Buy | 5.29 | 7,000 | 37,012 | 45,924 | Nov 16 04:47 PM |
OUST | MADDOCK ERNEST E | Director | Aug 21 | Buy | 6.02 | 7,000 | 42,140 | 38,924 | Aug 22 04:30 PM |
UCTT | MADDOCK ERNEST E | Director | Jul 31 | Buy | 13.40 | 1,000 | 13,404 | 6,430 | Aug 02 04:11 PM |
MU | MADDOCK ERNEST E | SVP & Chief Financial Officer | Aug 11 | Buy | 27.89 | 3,400 | 94,824 | 192,385 | Aug 15 05:08 PM |
MU | MADDOCK ERNEST E | CFO & VP, Finance | Jan 21 | Buy | 10.69 | 10,000 | 106,944 | 123,256 | Jan 25 04:54 PM |
MU | MADDOCK ERNEST E | CFO & VP, Finance | Dec 24 | Buy | 14.32 | 10,000 | 143,200 | 113,256 | Dec 28 04:46 PM |
MU | MADDOCK ERNEST E | CFO & VP, Finance | Jul 09 | Buy | 17.50 | 5,000 | 87,500 | 38,900 | Jul 10 04:33 PM |
LRCX | MADDOCK ERNEST E | Chief Financial Officer | Feb 05 | Option Exercise | 20.21 | 12,030 | 243,126 | 0 | Feb 07 01:29 PM |
LRCX | MADDOCK ERNEST E | Chief Financial Officer | Feb 05 | Sale | 42.28 | 12,030 | 508,636 | 0 | Feb 07 01:29 PM |
LRCX | MADDOCK ERNEST E | Chief Financial Officer | Jan 28 | Option Exercise | 20.21 | 12,450 | 251,614 | 0 | Jan 30 05:17 PM |
LRCX | MADDOCK ERNEST E | Chief Financial Officer | Jan 28 | Sale | 41.69 | 12,450 | 519,001 | 0 | Jan 30 05:17 PM |
LRCX | MADDOCK ERNEST E | Chief Financial Officer | Mar 02 | Option Exercise | 20.21 | 25,000 | 505,250 | 0 | Mar 04 02:44 PM |
LRCX | MADDOCK ERNEST E | Chief Financial Officer | Mar 02 | Sale | 56.65 | 25,000 | 1,416,175 | 38,259 | Mar 04 02:44 PM |
LRCX | MADDOCK ERNEST E | Chief Financial Officer | Dec 07 | Sale | 50.00 | 3,050 | 152,500 | 42,591 | Dec 08 02:37 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite